Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ayala Pharmaceuticals Inc (AYLA)

Ayala Pharmaceuticals Inc (AYLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,464
  • Shares Outstanding, K 14,821
  • Annual Sales, $ 3,510 K
  • Annual Income, $ -40,250 K
  • 60-Month Beta 1.98
  • Price/Sales 4.45
  • Price/Cash Flow N/A
  • Price/Book 0.91
Trade AYLA with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.52
  • Most Recent Earnings $-0.66 on 11/04/22
  • Latest Earnings Date 11/21/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.75
  • Number of Estimates 1
  • High Estimate -0.75
  • Low Estimate -0.75
  • Prior Year -0.66
  • Growth Rate Est. (year over year) -13.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3568 +41.14%
on 01/03/23
0.5906 -14.73%
on 01/10/23
+0.0034 (+0.68%)
since 12/16/22
3-Month
0.3568 +41.14%
on 01/03/23
0.9611 -47.60%
on 10/19/22
-0.4079 (-44.75%)
since 10/18/22
52-Week
0.3568 +41.14%
on 01/03/23
7.3100 -93.11%
on 01/19/22
-6.3364 (-92.64%)
since 01/18/22

Most Recent Stories

More News
Ayala Pharmaceuticals: Fiscal Q4 Earnings Snapshot

Ayala Pharmaceuticals: Fiscal Q4 Earnings Snapshot

AYLA : 0.5036 (+5.84%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IAA, POSH, AYLA, AGFS

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

IAA : 39.89 (-0.10%)
POSH : 17.90 (unch)
AYLA : 0.5036 (+5.84%)
AGFS : 3.00 (+0.33%)
Ayala Pharmaceuticals, Inc. (AYLA) Reports Q3 Loss, Lags Revenue Estimates

Ayala Pharmaceuticals, Inc. (AYLA) delivered earnings and revenue surprises of -20% and 88.63%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

AYLA : 0.5036 (+5.84%)
OPTN : 1.0100 (+15.09%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FORG, AYLA, SPNE, OFIX

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

FORG : 23.21 (+6.08%)
AYLA : 0.5036 (+5.84%)
SPNE : 9.54 (+8.29%)
OFIX : 13.60 (+2.72%)
AYLA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Ayala Pharmaceuticals, Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) and Advaxis, Inc. is fair to Ayala shareholders. Upon completion of the...

AYLA : 0.5036 (+5.84%)
Corcept (CORT) Up More Than 20% in Past 3 Months: Here's Why

Corcept's (CORT) Cushing's syndrome drug, Korlym, is witnessing higher sales and a strong uptake since its approval. Other pipeline candidates are also advancing well.

MRK : 127.51 (-0.58%)
CORT : 24.52 (-2.15%)
FUSN : 21.45 (-0.19%)
AYLA : 0.5036 (+5.84%)
Ayala Pharmaceuticals, Inc. (AYLA) Upgraded to Buy: Here's Why

Ayala Pharmaceuticals, Inc. (AYLA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

AYLA : 0.5036 (+5.84%)
Pacira (PCRX) Up on Data From Exparel Label Expansion Study

Pacira (PCRX) reports encouraging top-line data from the phase III study evaluating Exparel as a single-dose femoral nerve block in the adductor canal for total knee arthroplasty. Shares rise.

PCRX : 27.21 (-0.40%)
FUSN : 21.45 (-0.19%)
ASRT : 1.0300 (+1.98%)
AYLA : 0.5036 (+5.84%)
Q2 Financial Results Send Micro Cap Soaring

A small %Biotech company saw its shares trading higher during Tuesday’s session after the company announced its second quarter financial results for 2022. Some financial highlights from the press release...

AYLA : 0.5036 (+5.84%)
Infinity Pharmaceuticals (INFI) Reports Q2 Loss, Tops Revenue Estimates

Infinity (INFI) delivered earnings and revenue surprises of 7.14% and 1.63%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

INFI : 0.0080 (-50.00%)
AYLA : 0.5036 (+5.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Ayala Pharmaceuticals Inc. is a clinical-stage oncology company. It focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. Ayala Pharmaceuticals Inc. is based in Rehovot, Israel.

See More

Key Turning Points

3rd Resistance Point 0.6989
2nd Resistance Point 0.6343
1st Resistance Point 0.5690
Last Price 0.5036
1st Support Level 0.4391
2nd Support Level 0.3745
3rd Support Level 0.3092

See More

52-Week High 7.3100
Fibonacci 61.8% 4.6539
Fibonacci 50% 3.8334
Fibonacci 38.2% 3.0129
Last Price 0.5036
52-Week Low 0.3568

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar